NanoCelle B12

NanoCelle B12
Product Description

B12 is a water-soluble compound, thus this foundation study was to determine NanoCelle® improvement in water-soluble compounds when compared to other more traditional forms, such as tablets, liquid emulsions, capsules, and liposomes.

Study outcomes, published, and allowed TGA to approve hieighten absorption claim in advertising.

See: https://www.medlab.group/nanocelle-b12

Read more Show less

Medlab Group PTY LTD

  • Country/Region:
    Australia
  • On CPHI since:
    2024
  • Employees:
    1 - 24
Company types
Biopharmaceutical company
Primary activities
Clinical Research
Marketing Services Provider
Out-licensing specialist
View company profile
Categories
more categories Show less
Specifications
  • Details
    Market ready, TGA approved for Australian partner.

    All the benefits of the delivery platform NanoCelle, inclusive of patent protection and the therapeutic values of B12. 


    Variants include both activated in non activated forms of B12.


    Product dosage at 1,000iu, but can scale up to 5,000IU.


    Studies show that NanoCelle B12 is 5x more bioavailable than a tablet, and up too 13x more than a liposome. Outcome of this published studied allowed TGA to approve claim in advertising.
  • Selling Points
    Product Features; Product Performance
  • Supplied from
    Australia
More specifications Fewer specifications
Sales Markets
Show more Show less

Medlab Group PTY LTD

  • Country/Region:
    Australia
  • On CPHI since:
    2024
  • Employees:
    1 - 24
Company types
Biopharmaceutical company
Primary activities
Clinical Research
Marketing Services Provider
Out-licensing specialist
View company profile

More Products from Medlab Group PTY LTD (2)

  • NanoCelle

    Product NanoCelle

     See https://www.medlab.group/what-is-nanocelle

    NanoCelle can be deployed in many molecules to enhance absorption, and increase patient compliance whilst reducing side effects.
  • NRGBiotic

    Product NRGBiotic

    The Product - NRGBIOTIC™

    PATENTED (2036), PUBLISHED CLINICAL DATA

    The successful research undertaken provided for a first-in-class probiotic for the treatment of major depressive disorder, and subsequent patents in global territories, see here.

    The formulation was entered into ...

Medlab Group PTY LTD resources (2)

  • MEDLAB GROUP - out-licencing and consultancy

    News MEDLAB GROUP - out-licencing and consultancy

    Medlab Group is a private company specialising in delivery platforms, the human microbiome, and food supplement out-licencing.

    23 Mar 2024
  • NanoCelle Introductory video - 2 min 40 sec runtime

    Video NanoCelle Introductory video - 2 min 40 sec runtime

    NanoCelle® is a unique, patented delivery system with diverse applications.
    QUICK FACTS

    Improves compound solubility

    Improves absorption

    Reduces compound side effects

    By-passes 1st pass metabolism

    Improves Patient compliance

    Improved onset

    Significant in vitro and in vivo data

    RESEARCH HAS SHOWN:

    Extensive studies have been conducted, and results differ with different compounds, but over 400,000 NanoCelle® products have been dosed to patients with minimal side effects.

    In vitro characterization done in collaboration with the University of Sydney

    PK studies showed up too 5 times more compound is absorbed when compared to tablets, capsules, emulsions, and liposomes

    Bioequivalence studies showed comparable levels to tablets 10x its dose.

    Phase 1/2 studies showed safety, tolerability, and efficacy.

    RWE Studies showed safety, tolerability, and efficacy over extended periods of time

    The research portfolio showed no reported incident of CARPA.

    2024-07-22